<code id='B2104331A0'></code><style id='B2104331A0'></style>
    • <acronym id='B2104331A0'></acronym>
      <center id='B2104331A0'><center id='B2104331A0'><tfoot id='B2104331A0'></tfoot></center><abbr id='B2104331A0'><dir id='B2104331A0'><tfoot id='B2104331A0'></tfoot><noframes id='B2104331A0'>

    • <optgroup id='B2104331A0'><strike id='B2104331A0'><sup id='B2104331A0'></sup></strike><code id='B2104331A0'></code></optgroup>
        1. <b id='B2104331A0'><label id='B2104331A0'><select id='B2104331A0'><dt id='B2104331A0'><span id='B2104331A0'></span></dt></select></label></b><u id='B2104331A0'></u>
          <i id='B2104331A0'><strike id='B2104331A0'><tt id='B2104331A0'><pre id='B2104331A0'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:94534
          Photograph of a person wearing blue gloves counts money. -- health business coverage from STAT
          Adobe

          WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another.

          Medicare officials last week announced its major annual update to the way the program pays physicians. Along with other changes, it includes a policy that will boost payments to specialties that rely on evaluating and managing patients, as opposed to those that focus on procedures. But in Medicare, boosting payments in one area almost always means cutting them somewhere else. So to pay for that, doctors across the country will see a roughly 3% cut to a factor that determines how much Medicare pays them for caring for seniors.

          advertisement

          The change has pitted certain specialties against primary care doctors. A host of surgeons’ groups, including the American College of Surgeons, plainly criticized family physicians in a recent letter to Medicare, saying there’s no “valid justification” for the boost and calling it an “inappropriate” overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          EMA weighs against approval for Mirati's lung cancer drug
          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          What health policies could hitch a ride on a spending bill?

          StefaniReynolds/GettyImagesYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewsletterabo